Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pani

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
Expert Opinion on Pharmacotherapy|March 17, 2015
Changes and determination of dosing recommendations for medicinal products recently authorised in the European UnionFalk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, et al.
Neuropsychiatric Disease and Treatment|October 7, 2014
Towards a framework for treatment effectiveness in schizophreniaGeorg Juckel, Andrea de Bartolomeis, Philip Gorwood, et al.
British Journal of Pharmacology|January 11, 2003
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brainStefania Ruiu, Giorgio Marchese, Pier Luigi Saba, et al.
European Journal of Pharmacology|July 11, 2002
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effectGiorgio Marchese, Stefania Ruiu, Paola Casti, et al.
Scientia Pharmaceutica|July 15, 2015
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory PerspectiveJohn Joseph Borg, Paolo Tomasi, Luca Pani, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitorsGiovanni Loriga, Stefania Ruiu, Ilaria Manca, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2019
A case-control study of visually evoked postural responses in childhood with primary headachesCarlo Baraldi, Chiara Gherpelli, Matteo Alicandri Ciufelli, et al.
Pain Medicine (Malden, Mass.)|August 4, 2021
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective StudyCarlo Baraldi, Flavia Lo Castro, Andrea Negro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 19, 2012
The placebo arm in clinical studies for treatment of psychiatric disorders: a regulatory dilemmaChristine Gispen-de Wied, Violeta Stoyanova, Yang Yu, et al.
Brain Research|May 26, 2005
Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical studyMaria Antonietta Casu, Carla Pisu, Angela Sanna, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Expert Opinion on Pharmacotherapy|March 17, 2015
Changes and determination of dosing recommendations for medicinal products recently authorised in the European UnionFalk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, et al.
Neuropsychiatric Disease and Treatment|October 7, 2014
Towards a framework for treatment effectiveness in schizophreniaGeorg Juckel, Andrea de Bartolomeis, Philip Gorwood, et al.
British Journal of Pharmacology|January 11, 2003
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brainStefania Ruiu, Giorgio Marchese, Pier Luigi Saba, et al.
European Journal of Pharmacology|July 11, 2002
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effectGiorgio Marchese, Stefania Ruiu, Paola Casti, et al.
Scientia Pharmaceutica|July 15, 2015
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory PerspectiveJohn Joseph Borg, Paolo Tomasi, Luca Pani, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitorsGiovanni Loriga, Stefania Ruiu, Ilaria Manca, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2019
A case-control study of visually evoked postural responses in childhood with primary headachesCarlo Baraldi, Chiara Gherpelli, Matteo Alicandri Ciufelli, et al.
Pain Medicine (Malden, Mass.)|August 4, 2021
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective StudyCarlo Baraldi, Flavia Lo Castro, Andrea Negro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 19, 2012
The placebo arm in clinical studies for treatment of psychiatric disorders: a regulatory dilemmaChristine Gispen-de Wied, Violeta Stoyanova, Yang Yu, et al.
Brain Research|May 26, 2005
Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical studyMaria Antonietta Casu, Carla Pisu, Angela Sanna, et al.
Pageof 14